Cargando…
Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report
BACKGROUND: Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme for producing γ-aminobutyric acid, and it has been suggested that antibodies against GAD play a role in neurological conditions and type 1 diabetes. However, it is not known whether dementia appears as the sole neurological ma...
Autores principales: | Takagi, Masahito, Yamasaki, Hiroshi, Endo, Keiko, Yamada, Tetsuya, Kaneko, Keizo, Oka, Yoshitomo, Mori, Etsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292981/ https://www.ncbi.nlm.nih.gov/pubmed/22188660 http://dx.doi.org/10.1186/1471-2377-11-156 |
Ejemplares similares
-
Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study
por: Takagi, Masahito, et al.
Publicado: (2013) -
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995) -
Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023) -
Autoimmune musicogenic epilepsy associated with anti‐glutamic acid decarboxylase antibodies and Stiff‐person syndrome
por: Jesus‐Ribeiro, Joana, et al.
Publicado: (2019) -
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity
por: Marwaha, R.K., et al.
Publicado: (2013)